Loading clinical trials...
Loading clinical trials...
Phase II Study of a Combination Chemotherapy of DICE in the Patients With NK/T Cell Lymphoma
Conditions
Interventions
IFO, VP-16, DDP, DXM
Locations
1
China
Fudan University Cancer Hospital
Shanghai, Shanghai Municipality, China
Start Date
March 1, 2007
Primary Completion Date
December 1, 2010
Completion Date
December 1, 2010
Last Updated
September 8, 2010
NCT05529069
NCT06337318
NCT07388563
NCT06263491
NCT05139017
NCT07350863
Lead Sponsor
Fudan University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions